[Pregnancy-associated venous thromboembolic disease: prediction, prevention, and therapy].

Abstract excerpt

Thromboembolic disease remains a leading cause of maternal mortality during pregnancy and the puerperium. Rational and risk-adapted administration of heparin prophylaxis depends on 1. the identification of those women who have an increased risk of thrombosis and 2. the accurate quantification of this risk. In women without prior thrombosis, the presence of a heterozygous factor V Leiden or heterozygous G20210A...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antiphospholipid Syndrome
• Share to Mutation
• Share to Pregnancy